NIPRO Cellentia™-H Hemodialyzer Cellentia™-15HRecalls & reported problems
Nipro Medical Corporation · CELLULOSE TRIACETATE HEMODIALYZER 1.5m² / Max.TMP 66kPa (500mmHg) · Class 2
All models of NIPRO Cellentia-H Hemodialyzer (4)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 2
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00383790004381), received between Jul 19, 2019 and Jul 19, 2019 — classified as 2 deaths.
The most frequently reported specific device problem is “Device Alarm System” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Alarm System1
- Leak/Splash1
Patient problems
- Death2
- Decreased Respiratory Rate1
- Edema1
- High Blood Pressure/ Hypertension1
- Hypoventilation1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathJul 19, 2019Device Alarm System
PATIENT WAS IN THE HOSPITAL AND STARTED AS AN ACUTE KIDNEY INJURY PATIENT. APPROXIMATELY 4.5HRS INTO ACUTE HEMODIALYSIS TREATMENT (TREATMENT INITIATED AT 14:42) AT THE HOSPITAL, MACHINE ALARMED FOR BLOOD LEAK, IMMEDIATELY PRIOR TO THE ALARM HE WAS STARTED ON A NITROGLYCERIN DRIP AS WELL AS NICARDIPINE AND SEEMS TO HAVE BEEN ON THE HEMOPURE, FENTANYL AND MIDAZOLAM ALL DAY, PATIENT DEVELOPED A SEVERE SPIKE IN BLOOD PRESSURE PRIOR TO THE ALARM (PATIENT REMOVED FROM TREATMENT AT 19:35). DIALYZER WAS NOT TESTED FOR BLOOD LEAK TO CONFIRM POSITIVE BLOOD LEAK. DURING TREATMENT: PATIENT WAS NOTED TO BE HYPERTENSIVE IN WITH SYSTOLIC IN THE 180-190S AROUND 6:45PM. THIS HAPPENED ACUTELY, HIS BP WAS AROUND 120/60 FOR MOST OF THE DAY. HIS BP RAPIDLY WENT UP TO 260S SBP WITHIN 15 MINUTES. LIKELY SECONDARY TO HEMOPURE (THE DRUG IS KNOWN TO HAVE VASOACTIVE EFFECTS AND ALSO CAUSE VOLUME OVERLOAD) AND EPO (40,000 UNITS) THAT HE GOT EARLIER TODAY. STARTED NITRO DRIP TO TITRATE FOR SBP 130-160 MMHG WITHIN 15 MIN OF NOTING HYPERTENSION. AROUND 7:10 PM PATIENT'S VENTILATOR STARTED TO ALARM AND HIS MINUTE VENTILATION WAS NOTED TO HAVE DIPPED ACUTELY FROM 14-18 TO 7. HE ALSO WAS NOTED TO HAVE STOPPED MAKIN
Patient problems: Death; Decreased Respiratory Rate; Edema; High Blood Pressure/ Hypertension; Hypoventilation
MAUDE report 8809373 ↗DeathJul 19, 2019Leak/Splash; Leak/Splash
PATIENT WAS IN THE HOSPITAL AND STARTED AS AN ACUTE KIDNEY INJURY PATIENT. APPROXIMATELY 4.5HRS INTO ACUTE HEMODIALYSIS TREATMENT (TREATMENT INITIATED AT 14:42) AT THE HOSPITAL, MACHINE ALARMED FOR BLOOD LEAK, IMMEDIATELY PRIOR TO THE ALARM HE WAS STARTED ON A NITROGLYCERIN DRIP AS WELL AS NICARDIPINE AND SEEMS TO HAVE BEEN ON THE HEMOPURE, FENTANYL AND MIDAZOLAM ALL DAY, PATIENT DEVELOPED A SEVERE SPIKE IN BLOOD PRESSURE PRIOR TO THE ALARM (PATIENT REMOVED FROM TREATMENT AT 19:35). DIALYZER WAS NOT TESTED FOR BLOOD LEAK TO CONFIRM POSITIVE BLOOD LEAK. DURING TREATMENT: PATIENT WAS NOTED TO BE HYPERTENSIVE IN WITH SYSTOLIC IN THE 180-190S AROUND 6:45PM. THIS HAPPENED ACUTELY,HIS BP WAS AROUND 120/60 FOR MOST OF THE DAY. HIS BP RAPIDLY WENT UP TO 260S SBP WITHIN 15 MINUTES. LIKELY SECONDARY TO HEMOPURE (THE DRUG IS KNOWN TO HAVE VASOACTIVE EFFECTS AND ALSO CAUSE VOLUME OVERLOAD) AND EPO (40,000 UNITS) THAT HE GOT EARLIER TODAY. STARTED NITRO DRIP TO TITRATE FOR SBP 130-160 MMHG WITHIN 15 MIN OF NOTING HYPERTENSION. AROUND 7:10 PM PATIENT'S VENTILATOR STARTED TO ALARM AND HIS MINUTE VENTILATION WAS NOTED TO HAVE DIPPED ACUTELY FROM 14-18 TO 7. HE ALSO WAS NOTED TO HAVE STOPPED MAKING
Patient problems: Death
MAUDE report 8809333 ↗
Other Dialyzer, high permeability with or without sealed dialysate system devices
- Optiflux® 0500318EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall6 deaths2,849 reports
- 2008® Series Hemodialysis Machines 190713Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls37 deaths893 reports
- 2008T BlueStar Hemodialysis Machine 191126Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system5 recalls10 deaths441 reports
- 2008® Series Hemodialysis Machines 190766Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls15 deaths370 reports
- 2008T BlueStar Hemodialysis Machine 191130Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls7 deaths272 reports
- 2008® Series Hemodialysis Machines 190610Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall15 deaths335 reports
- Optiflux® 0500320EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system2 recalls242 reports
- REVACLEAR 300Gambro Renal Products, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls125 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page